Eli Lilly PE Ratio 2006-2018 | LLY

Current and historical p/e ratio for Eli Lilly (LLY) from 2006 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Eli Lilly PE ratio as of October 19, 2018 is 22.25.
Eli Lilly PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2018-10-19 111.92 0.00
2018-06-30 84.86 $-0.14 0.00
2018-03-31 76.42 $1.06 72.09
2017-12-31 82.82 $-0.20 0.00
2017-09-30 83.35 $2.11 39.50
2017-06-30 79.68 $2.31 34.49
2017-03-31 80.91 $2.07 39.09
2016-12-31 70.28 $2.58 27.24
2016-09-30 76.20 $2.30 33.13
2016-06-30 74.29 $2.32 32.02
2016-03-31 67.48 $2.17 31.10
2015-12-31 78.42 $2.26 34.70
2015-09-30 77.40 $2.21 35.02
2015-06-30 76.76 $1.93 39.77
2015-03-31 66.34 $2.05 32.36
2014-12-31 62.55 $2.23 28.05
2014-09-30 58.37 $2.50 23.35
2014-06-30 55.51 $3.14 17.68
2014-03-31 52.13 $3.57 14.60
2013-12-31 44.76 $4.31 10.38
2013-09-30 43.74 $4.38 9.99
2013-06-30 42.32 $4.45 9.51
2013-03-31 48.50 $4.17 11.63
2012-12-31 41.74 $3.66 11.40
2012-09-30 39.71 $3.69 10.76
2012-06-30 35.53 $3.62 9.82
2012-03-31 32.95 $3.86 8.54
2011-12-31 33.59 $3.90 8.61
2011-09-30 29.49 $4.18 7.05
2011-06-30 29.53 $4.25 6.95
2011-03-31 27.32 $4.40 6.21
2010-12-31 26.84 $4.58 5.86
2010-09-30 27.59 $4.36 6.33
2010-06-30 24.97 $4.04 6.18
2010-03-31 26.62 $3.88 6.86
2009-12-31 25.88 $3.95 6.55
2009-09-30 23.61 $-0.19 0.00
2009-06-30 24.39 $-1.48 0.00
2009-03-31 23.20 $-1.66 0.00
2008-12-31 27.60 $-1.89 0.00
2008-09-30 29.74 $2.20 13.52
2008-06-30 30.88 $3.48 8.87
2008-03-31 34.17 $3.21 10.65
2007-12-31 35.04 $2.71 12.93
2007-09-30 37.06 $2.05 18.08
2007-06-30 36.11 $2.00 18.06
2007-03-31 34.46 $2.15 16.03
2006-12-31 33.16 $2.45 13.54
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $120.201B $22.871B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $373.058B 17.49
Pfizer (PFE) United States $264.902B 15.51
Novartis AG (NVS) Switzerland $202.059B 17.26
Merck (MRK) United States $195.069B 17.23
AbbVie (ABBV) United States $133.211B 13.01
Sanofi (SNY) France $111.785B 14.15
Novo Nordisk (NVO) Denmark $105.487B 16.86
GlaxoSmithKline (GSK) United Kingdom $101.355B 13.53
AstraZeneca (AZN) United Kingdom $99.315B 10.92
Bristol-Myers Squibb (BMY) United States $88.755B 16.07